Can we design a better anti‐cytokine therapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can we design a better anti‐cytokine therapy?

Published:2017-05-25 Issue:3 Volume:102 Page:783-790
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:J Leuk Biol

Author:

Drutskaya Marina S.¹²,Efimov Grigory A.¹³,Kruglov Andrei A.¹²⁴,Nedospasov Sergei A.¹²⁴

Affiliation:

1. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia;

2. Lomonosov Moscow State University, Moscow, Russia;

3. National Research Center for Hematology, Moscow, Russia; and

4. German Rheumatism Research Center (DRFZ), Berlin, Germany

Funder

Russian Science Foundation

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1189/jlb.3MA0117-025R

Reference92 articles.

1. Anti-TNF Therapy, from Rationale to Standard of Care: What Lessons Has It Taught Us?

2. Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

3. Anti-TNF therapy: past, present and future

4. TNF- antagonists beyond approved indications: stories of success and prospects for the future

5. Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of extracorporeal hemadsorption on mortality in critically ill COVID-19 patients in the intensive care unit;The International Journal of Artificial Organs;2024-09-13

2. Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review);Molecular Medicine Reports;2024-04-09

3. TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond;Nature Reviews Rheumatology;2023-08-04

4. Update on Innate and Adaptive Immunity in Cystic Fibrosis;Clinics in Chest Medicine;2022-12

5. Resveratrol and its derivates improve inflammatory bowel disease by targeting gut microbiota and inflammatory signaling pathways;Food Science and Human Wellness;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3